Cargando…

P72. Transgenic expression of a chimeric signaling receptor to facilitate T cell costimulation in the tumour environment

Detalles Bibliográficos
Autores principales:	Schlenker, R, Leisegang, M, Uckert, W, Noessner, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072292/ http://dx.doi.org/10.1186/2051-1426-2-S2-P46

Ejemplares similares

Turning tumor inhibition into activation: engineering T cells with chimeric signaling receptors
por: Schlenker, Ramona, et al.
Publicado: (2014)

Augmenting adoptive T cell therapy through universal chimeric costimulators
por: Hanada, Ken-ichi, et al.
Publicado: (2013)

Chimeric antigen receptor (CAR)+ T cell selection method affects transgene efficacy
por: Rushworth, David, et al.
Publicado: (2013)

Identification of potential immunotherapeutic targets in antigen presentation and costimulation networks
por: Spaapen, Robbert, et al.
Publicado: (2014)

Costimulation to enhance the antitumor activity of CD19 eng T cells
por: Velasquez, Mireya, et al.
Publicado: (2015)

4-1BB Costimulation Ameliorates T Cell Exhaustion Induced by Tonic Signaling of Chimeric Antigen Receptors
por: Long, Adrienne H., et al.
Publicado: (2015)

P21. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention
por: Prinz, P, et al.
Publicado: (2014)

Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy
por: Khalil, Danny, et al.
Publicado: (2015)

Differential regulation of motility and immune synapses by CD28/ CTLA-4 costimulation in effector and regulatory T cells
por: Dilek, Nahzli, et al.
Publicado: (2012)

"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours
por: Champion, Brian R, et al.
Publicado: (2014)

Locally secreted Fc-OX40L is superior to systemic, antibody mediated, OX40 costimulation for combination immunotherapy
por: Fromm, George, et al.
Publicado: (2015)

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
por: Labiano, Sara, et al.
Publicado: (2014)

Coactivation of estrogen receptor alpha by the DEAD-box RNA helicases p68 and p72 and its role in breast cancer
por: Fuller-Pace, FV, et al.
Publicado: (2008)

P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
por: Krebs, K, et al.
Publicado: (2014)

P31. Genomic profiling and functional characterisation of a new myeloid cell type enriched in renal cell carcinoma
por: Brech, D, et al.
Publicado: (2014)

A role for immunotherapy: preventing macrophage anergy in the tumour environment
por: Elia, Androulla, et al.
Publicado: (2013)

P70. Development of clinically implementable imaging strategies for tracking T cell receptor-transgenic T cells
por: Mall, S, et al.
Publicado: (2014)

Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors
por: Tschernia, Nicholas, et al.
Publicado: (2014)

Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis
por: Priceman, Saul, et al.
Publicado: (2015)

Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
por: Drent, Esther, et al.
Publicado: (2015)

P02.72. A pilot investigation of alignment-based yoga for pediatric obesity
por: Hainsworth, K, et al.
Publicado: (2012)

Development of chimeric antigen receptor-redirected T cell therapy targeting L1-CAM in ovarian cancer
por: Hong, Hao, et al.
Publicado: (2013)

A chimeric antigen receptor against prostate-specific membrane antigen, a tumor vasculature target
por: Santoro, Stephen P, et al.
Publicado: (2013)

Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
por: Park, Anthony K, et al.
Publicado: (2015)

An unusual case of Ebstein anomaly in 72 year old woman
por: Ntalarizou, E, et al.
Publicado: (2013)

Dual targeting of the tumor and its associated vasculature using a single bispecific chimeric antigen receptor molecule
por: Byrd, Tiara, et al.
Publicado: (2014)

Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model
por: Berger, S Carolina, et al.
Publicado: (2014)

Preserving the owner’s autonomy in networks of patient registries and biobanks
por: Lablans, Martin, et al.
Publicado: (2014)

P12-07. Novel HIV vaccines using chimeric influenza HA vectors
por: Steinhauer, DA, et al.
Publicado: (2009)

Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma
por: Murayama, Yudai, et al.
Publicado: (2021)

P12-15. Replication enhancement of an alphaviral-lentiviral replicating chimeric particle (RCP) vaccine
por: Young, K, et al.
Publicado: (2009)

CD28, Costimulator or Agonist Receptor?
por: Margulies, David H.
Publicado: (2003)

P04.72. Towards a model for integrative medicine in the primary care of patients with chronic joint diseases and allergy
por: Jong, M, et al.
Publicado: (2012)

Enhanced glycolytic metabolism is associated with exhaustion and poor antitumor efficacy in a xenograft model of chimeric antigen receptor T cell therapy for sarcoma
por: Long, Adrienne H, et al.
Publicado: (2013)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)

Prediction of 1-year mortality of patients treated for more than 72 hours in an ICU
por: Steenbergen, S, et al.
Publicado: (2014)

Alarming levels of heat shock proteins 72 and 90α in critically ill children
por: Fitrolaki, M, et al.
Publicado: (2015)

Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors
por: Highfill, Steven L, et al.
Publicado: (2013)

GUCY2C-targeted chimeric antigen receptor expressing T cells extend survival in a therapeutic mouse model of metastatic colorectal cancer
por: Magee, Michael S, et al.
Publicado: (2013)

Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)
por: Schneider, Dina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bt4hag52ggojlkl6a2cqsl073k